
Laboratorios Farmaceuticos Rovi Sa (0ILL)
LSE
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 265.17M | 275.65M | 303.2M | 381.31M | 419.96M | 648.68M | 817.7M | 829.51M |
Operating Income | 26.81M | 16.67M | 15.9M | 41.84M | 73.49M | 181.57M | 256.05M | 220.13M |
Pre Tax Income | 27.88M | 17.52M | 16.68M | 41.88M | 72.58M | 182.63M | 257.97M | 220.41M |
Net Income | 26.09M | 17.24M | 17.9M | 39.27M | 61.06M | 153.08M | 199.67M | 170.34M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0.522 | 0.345 | 0.319 | 0.7 | 1.089 | 2.73 | 3.696 | 3.153 |
EBIT | 28.37M | 18.44M | 17.48M | 42.99M | 74.65M | 181.57M | 256.05M | 220.13M |
EBITDA | 37.83M | 28.15M | 27.94M | 60.05M | 93.14M | 203.03M | 278.92M | 244.46M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.